189 related articles for article (PubMed ID: 24323810)
1. Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke.
Zhang M; Mahadevan A; Amere M; Li H; Ganea D; Tuma RF
Transl Stroke Res; 2012 Sep; 3(3):348-56. PubMed ID: 24323810
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid and Cannabinoid-Related Receptors in the Myenteric Plexus of the Porcine Ileum.
Toschi A; Galiazzo G; Piva A; Tagliavia C; Mazzuoli-Weber G; Chiocchetti R; Grilli E
Animals (Basel); 2021 Jan; 11(2):. PubMed ID: 33494452
[TBL] [Abstract][Full Text] [Related]
3. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
Tai S; Vasiljevik T; Sherwood AM; Eddington S; Wilson CD; Prisinzano TE; Fantegrossi WE
Drug Alcohol Depend; 2018 Nov; 192():285-293. PubMed ID: 30300803
[TBL] [Abstract][Full Text] [Related]
4. Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia.
Ward SJ; Castelli F; Reichenbach ZW; Tuma RF
Life Sci; 2018 Feb; 195():1-5. PubMed ID: 29288767
[TBL] [Abstract][Full Text] [Related]
5. Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke.
Fernández-López D; Faustino J; Derugin N; Wendland M; Lizasoain I; Moro MA; Vexler ZS
Neuroscience; 2012 Apr; 207():307-15. PubMed ID: 22285309
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a CB
Yang W; Gong X; Sun H; Wu C; Suo J; Ji J; Jiang X; Shen J; He Y; Aisa HA
Eur J Med Chem; 2024 Feb; 265():116048. PubMed ID: 38150961
[TBL] [Abstract][Full Text] [Related]
7. Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis.
Rodrigues RS; Ribeiro FF; Ferreira F; Vaz SH; Sebastião AM; Xapelli S
Front Pharmacol; 2017; 8():516. PubMed ID: 28848435
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro.
Noone J; Rooney MF; Karavyraki M; Yates A; O'Sullivan SE; Porter RK
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004445
[TBL] [Abstract][Full Text] [Related]
9. CB
Gallo Afflitto G; Aiello F; Scuteri D; Bagetta G; Nucci C
Biomed Pharmacother; 2022 Jun; 150():112981. PubMed ID: 35468582
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.
Zarruk JG; Fernández-López D; García-Yébenes I; García-Gutiérrez MS; Vivancos J; Nombela F; Torres M; Burguete MC; Manzanares J; Lizasoain I; Moro MA
Stroke; 2012 Jan; 43(1):211-9. PubMed ID: 22020035
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
[TBL] [Abstract][Full Text] [Related]
12. Functional CB2 type cannabinoid receptors at CNS synapses.
Morgan NH; Stanford IM; Woodhall GL
Neuropharmacology; 2009 Sep; 57(4):356-68. PubMed ID: 19616018
[TBL] [Abstract][Full Text] [Related]
13. Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint.
Zamith Cunha R; Zannoni A; Salamanca G; De Silva M; Rinnovati R; Gramenzi A; Forni M; Chiocchetti R
Front Vet Sci; 2023; 10():1045030. PubMed ID: 36937015
[TBL] [Abstract][Full Text] [Related]
14. A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain.
Yu XH; Cao CQ; Martino G; Puma C; Morinville A; St-Onge S; Lessard É; Perkins MN; Laird JMA
Pain; 2010 Nov; 151(2):337-344. PubMed ID: 20696525
[TBL] [Abstract][Full Text] [Related]
15. Differential Regulation of MMPs, Apoptosis and Cell Proliferation by the Cannabinoid Receptors CB1 and CB2 in Vascular Smooth Muscle Cells and Cardiac Myocytes.
Greiner B; Sommerfeld M; Kintscher U; Unger T; Kappert K; Kaschina E
Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36552027
[TBL] [Abstract][Full Text] [Related]
16. A new target to ameliorate the damage of periodontal disease: The role of transient receptor potential vanilloid type-1 in contrast to that of specific cannabinoid receptors in rats.
Ossola CA; Balcarcel NB; Astrauskas JI; Bozzini C; Elverdin JC; Fernández-Solari J
J Periodontol; 2019 Nov; 90(11):1325-1335. PubMed ID: 31077362
[TBL] [Abstract][Full Text] [Related]
17. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
18. Clinical Importance of Cannabinoid Type 1 Receptor (CB1R) and Cannabinoid Type 2 Receptor (CB2R) Expression in Renal Cell Carcinoma.
Deligiannis D; Anastasiou I; Mitropoulos D; Mitsos P; Theocharis S
Cureus; 2024 Feb; 16(2):e55121. PubMed ID: 38420293
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
20. Localisation of Cannabinoid and Cannabinoid-Related Receptors in the Horse Ileum.
Galiazzo G; Tagliavia C; Giancola F; Rinnovati R; Sadeghinezhad J; Bombardi C; Grandis A; Pietra M; Chiocchetti R
J Equine Vet Sci; 2021 Sep; 104():103688. PubMed ID: 34416995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
